FOXO Technologies Inc., a company listed on the NYSE American LLC under the symbol 'FOXO', has filed a prospectus supplement to update and supplement information contained in a previous prospectus dated September 6, 2023. This filing pertains to the potential offer and resale of up to 3,668,750 shares of Class A common stock by selling stockholders named in the prospectus or their permitted transferees. The shares in question include those purchased in two separate tranches as part of a private placement transaction known as the 2023 PIPE Second Round. The company will not receive any proceeds from the sale of shares by the selling stockholders. The closing price of FOXO's Class A Common Stock and Public Warrants on January 22, 2024, was $0.2950 and $0.0025, respectively. Additionally...Show More

FOXO Technologies Inc., a company listed on the NYSE American LLC under the symbol 'FOXO', has filed a prospectus supplement to update and supplement information contained in a previous prospectus dated September 6, 2023. This filing pertains to the potential offer and resale of up to 3,668,750 shares of Class A common stock by selling stockholders named in the prospectus or their permitted transferees. The shares in question include those purchased in two separate tranches as part of a private placement transaction known as the 2023 PIPE Second Round. The company will not receive any proceeds from the sale of shares by the selling stockholders. The closing price of FOXO's Class A Common Stock and Public Warrants on January 22, 2024, was $0.2950 and $0.0025, respectively. Additionally, FOXO Technologies has entered into a Master Software and Services Agreement with KR8 AI Inc., effective January 12, 2024. The agreement grants FOXO a perpetual license to use KR8 AI Inc.'s products within the U.S., Canada, and Mexico to develop an AI machine learning epigenetic app aimed at enhancing health, wellness, and longevity. The agreement includes an initial license and development fee of $2,500,000, a monthly maintenance fee of $50,000, and a royalty of 15% of subscriber revenues. The agreement also outlines terms for termination and the conversion of the license to non-exclusive should minimum royalty payments not be met. The date of this prospectus supplement is January 23, 2024.